Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product

PURPOSE: To evaluate the efficacy and safety of the biosimilar infliximab in adult patients with inflammatory arthritis switched from reference product in our center. PATIENTS AND METHODS: In April 2014, patients attending our rheumatology service for infliximab infusions were switched from referenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalla, Abuelmagd, Byrne, Niamh, Conway, Richard, Walsh, Thomas, Mannion, Geraldine, Hanly, Michael, O’Sullivan, Miriam, Curran, Ann Maria, Carey, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349501/
https://www.ncbi.nlm.nih.gov/pubmed/28331376
http://dx.doi.org/10.2147/OARRR.S124975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349501/
https://www.ncbi.nlm.nih.gov/pubmed/28331376
http://dx.doi.org/10.2147/OARRR.S124975

Ejemplares similares